Source: International Business Times
Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat Biosciences. Getty Images Anthropic is expanding into biotechnology through drug-development partnerships, its own biology laboratory, and the acquisition of a company researching rare muscular diseases, bringing the artificial intelligence company deeper into the search for new medicines. In a new announcement, Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat Biosciences.
Aller á la Source
Nouvelles connexes
